Connect with us

Business

Struggling cannabis companies turn to Canadian insolvency law

Published

on

An unusual number of cannabis companies have used a Canadian corporate insolvency law called the Companies’ Creditors Arrangement Act (CCAA) in 2022, a trend that demonstrates both the marijuana industry’s financial challenges and one possible solution to keep businesses from slipping completely underwater.

Fourteen of the 35 CCAA filings in Canada – or 40% – between Jan. 1 and Dec. 22 have involved companies operating in the cannabis space in one way or another:

  • Eve & Co. and related companies.
  • Choom Holdings and related companies.
  • MJardin Group, GrowForce Holdings and related companies.
  • Zenabis Global and related companies.
  • Sproutly and Toronto Herbal Remedies.
  • MPX International Corp. and related companies.
  • Speakeasy Cannabis Club.
  • Medipure Pharmaceuticals and Medipure Holdings.
  • Superette and related companies.
  • Flower One Holdings and related companies.
  • The Flowr Corp.
  • CannaPiece Group.
  • Trichome Financial Corp. and related companies.
  • Lightbox Enterprises (Dutch Love Cannabis).

“Going back a couple years ago, the markets were very frothy, and the ability to raise equity financing meant that there was a ready supply of cash in the industry,” said Ranjeev Dhillon, a partner with Canadian law firm McCarthy Tétrault and co-lead of the firm’s cannabis law group.

Many businesses proceeded with the expectation that capital would continue to flow, Dhillon added.

“That is no longer the case,” he said.

“And because they have no cash now and this is a relatively thin-margin business and (a) capital-heavy business at times, they have no more means of being able to raise cash anymore or pay back debts.

“And that’s why you’re seeing this increase in CCAA.”

Jane Dietrich, a partner in the restructuring and insolvency group at Canadian law firm Cassels Brock & Blackwell, said the cannabis sector CCAA trend started in 2020 and appears to be accelerating.

In part, she attributes the cannabis CCAA trend to the newness of the regulated industry.

“There’s a lot of rationalization happening as people figure out which of the companies are going to succeed and which are struggling,” Dietrich said.

Filing a CCAA can also be a useful option for certain U.S.-based cannabis companies that don’t have access to Chapter 11 bankruptcy protection in their home country because of the federal illegality of marijuana.

“To the extent they have a Canadian connection or Canadian link, they seek to file up here and then deal with their financial difficulties in a CCAA proceeding,” explained Jamey Gage, national chair of McCarthy Tétrault’s bankruptcy and restructuring group.

For example, Nevada cultivator Flower One Holdings filed for CCAA protection in October via its Canadian parent company.

Understanding the CCAA

The CCAA is one of two Canadian federal insolvency statutes, alongside the Bankruptcy and Insolvency Act.

Gage said the CCAA is generally used for larger companies with more complex restructurings and is common in the cannabis space.

The CCAA is available to companies that meet three criteria:

  • They are a Canadian entity – or they have Canadian assets or do business in Canada.
  • They have debts of at least 5 million Canadian dollars ($3.7 million).
  • They are insolvent.

Those companies may apply for an initial court order “that prevents creditors, contract counterparties and others from exercising their rights and remedies while providing the company with some breathing room to try to negotiate a restructuring of its debts with its creditors, or concurrently conduct a sale process seeking to find a going-concern buyer, or investment financing,” Gage said.

The initial creditor protection order is typically granted for 10 days, after which the company needs an extension.

The insolvent company’s creditors have an opportunity to object to the terms of the initial creditor protection order before it gets extended.

CCAA proceedings usually resolve in one of three ways, Gage explained:

  • A “plan of arrangement,” voted on by the creditors and subject to court approval to restructure and continue the business “with a deal worked out with the creditors to reduce the debts (and) maybe raise more capital.”
  • A court-approved sale and investment solicitation process (SISP) in which the insolvent company seeks offers to buy or invest in the business.
  • A liquidation.

Gage said a SISP generally resolves faster than a plan of arrangement.

Some recent cannabis industry CCAA proceedings have involved debtor-in-possession (DIP) loans and related stalking-horse bids during the sale and investment solicitation process.

DIP loans allow insolvent companies to borrow funding to keep operating during the CCAA process, while the DIP lender receives priority over the company’s other debts.

“That can be a key tool, sometimes, in what may drive companies to file for CCAA protection, when they can’t find any more financing outside of court protection,” Gage said.

That DIP loan may be related to a sales process: In some cases, the DIP lender seeks to acquire the insolvent company – or at least some of its assets.

By putting in a stalking-horse bid as part of the sales process, the DIP lender sets a starting price for all interested bidders.

“The benefit from the (insolvent) company’s perspective is that, by having a stalking-horse bid in place, it creates both a bidding floor and some kind of auction tension to try to drive prices higher,” Gage said.

“But it also creates stability in the meantime so that employees, customers (and) other stakeholders know that there’s going to be a going-concern solution.”

That stability means suppliers might be more comfortable doing business with the insolvent company and employees might be less likely to leave “because they know that there’s more prospect for a job at the end of it.”

The DIP lender doesn’t have to be the stalking-horse bidder, although Gage said that arrangement is common in the cannabis industry.

In one recent example, Toronto-based cultivator The Flowr Corp. sold its assets to its DIP lender after the lender made a stalking-horse bid.

“I think what you’re seeing is … a sales process in which the stalking-horse bidder inevitably ends up taking the assets because there’s not really a large pool of buyers out there for these assets,” Dhillon said.

“And if there are assets to be purchased, they’re being purchased at heavy discounts to the initial capital outlay.”

More cannabis CCAA action expected

Dhillon expects 2023 will be a busy year for cannabis insolvency filings in Canada.

With capital being difficult to raise and corporate debt coming due, he said, “CCAA is one of the only viable options here to see that through.”

For Canadian cannabis companies, Dhillon said deferred government excise tax debts could also lead to new CCAA filings next year.

“At some point, the government’s going to become more aggressive about collecting (those bills),” Dhillon said.

Cassels attorney Dietrich also expects the cannabis CCAA trend to continue into 2023.

“I think it was probably artificially low in 2020 and into the start of 2021,” she said, citing government support for businesses during the COVID-19 pandemic.

“I think that hid a lot of the troubled companies that were out there,” Dietrich added.

“And that’s one of the reasons I think that it will continue, because we’re starting to see more and more of that relief go away and it exposes companies who are having issues.”

Facing up to an insolvent business isn’t easy, but McCarthy lawyer Gage recommends business leaders don’t wait too long to address their financial challenges.

“If you leave it too late, your options are limited and you can get a pretty bad outcome,” he said.

Insolvent companies that have exhausted their cash reserves will have less time to find a way forward, even if they can secure DIP financing, Gage added.

“A short period of time means a shorter sale process, a shorter period of time to negotiate with people, it probably means more drastic cash conservation measures – cost-cutting, letting even more employees go …

“Once you’re cutting into the muscle and not just cutting the fat, you’re starting to hamper the attractiveness of your business as a going concern.”

Source: https://mjbizdaily.com/struggling-cannabis-companies-turn-to-canadian-insolvency-law-ccaa/

Business

New Mexico cannabis operator fined, loses license for alleged BioTrack fraud

Published

on

New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.

The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.

Golden Roots operates the The Cannabis Revolution Dispensary.

The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.

The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.

Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.

After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.

In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.

The company requested a hearing, which the regulator scheduled for Sept. 1.

At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.

Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.

Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.

The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:

Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.

Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/

Continue Reading

Business

Marijuana companies suing US attorney general in federal prohibition challenge

Published

on

Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.

According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”

Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.

The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”

The companies want the case to go before the U.S. Supreme Court.

They hired prominent law firm Boies Schiller Flexner to represent them.

The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.

Similar challenges to the federal Controlled Substances Act (CSA) have failed.

One such challenge led to a landmark Supreme Court decision in 2005.

In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.

In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.

Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.

“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.

“Moreover, the facts on which those precedents are based are no longer true.”

Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”

While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.

“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”

Source: https://mjbizdaily.com/marijuana-companies-suing-us-attorney-general-to-overturn-federal-prohibition/

Continue Reading

Business

Alabama to make another attempt Dec. 1 to award medical cannabis licenses

Published

on

Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.

The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).

Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.

Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.

That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.

Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.

Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.

A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.

Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News